Cargando…
Identification of PANoptosis-Based Prognostic Signature for Predicting Efficacy of Immunotherapy and Chemotherapy in Hepatocellular Carcinoma
BACKGROUND: PANoptosis has been a research hotspot, but the role of PANoptosis in hepatocellular carcinoma (HCC) remains widely unknown. Drug resistance and low response rate are the main limitations of chemotherapy and immunotherapy in HCC. Thus, construction of a prognostic signature to predict pr...
Autores principales: | Xiong, Xiaofeng, Song, Qianben, Jing, Mengjia, Yan, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260314/ https://www.ncbi.nlm.nih.gov/pubmed/37313428 http://dx.doi.org/10.1155/2023/6879022 |
Ejemplares similares
-
Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2023) -
Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy
por: Yi, Xianyanling, et al.
Publicado: (2023) -
Robust analysis of a novel PANoptosis-related prognostic gene signature model for hepatocellular carcinoma immune infiltration and therapeutic response
por: Wei, Yongguang, et al.
Publicado: (2023) -
Identification of PANoptosis-relevant subgroups to evaluate the prognosis and immune landscape of patients with liver hepatocellular carcinoma
por: Zhang, Zhengwei, et al.
Publicado: (2023) -
Prognostic pyroptosis-related lncRNA signature predicts the efficacy of immunotherapy in hepatocellular carcinoma
por: Cheng, Zina, et al.
Publicado: (2022)